Logo image of ISPC

ISPECIMEN INC (ISPC) Stock Fundamental Analysis

NASDAQ:ISPC - Nasdaq - US45032V2079 - Common Stock

2.37  -0.48 (-16.84%)

After market: 2.4896 +0.12 (+5.05%)

Fundamental Rating

3

Taking everything into account, ISPC scores 3 out of 10 in our fundamental rating. ISPC was compared to 39 industry peers in the Health Care Technology industry. The financial health of ISPC is average, but there are quite some concerns on its profitability. ISPC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ISPC had negative earnings in the past year.
ISPC had a negative operating cash flow in the past year.
In the past 5 years ISPC always reported negative net income.
In the past 5 years ISPC always reported negative operating cash flow.
ISPC Yearly Net Income VS EBIT VS OCF VS FCFISPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

ISPC's Return On Assets of -84.55% is on the low side compared to the rest of the industry. ISPC is outperformed by 83.78% of its industry peers.
With a Return On Equity value of -202.01%, ISPC is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -84.55%
ROE -202.01%
ROIC N/A
ROA(3y)-45.63%
ROA(5y)-64.82%
ROE(3y)-64.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISPC Yearly ROA, ROE, ROICISPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 400 600 800

1.3 Margins

ISPC has a Gross Margin (47.97%) which is comparable to the rest of the industry.
ISPC's Gross Margin has improved in the last couple of years.
ISPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.92%
GM growth 5Y2.16%
ISPC Yearly Profit, Operating, Gross MarginsISPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

ISPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ISPC has less shares outstanding
The number of shares outstanding for ISPC has been reduced compared to 5 years ago.
There is no outstanding debt for ISPC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ISPC Yearly Shares OutstandingISPC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ISPC Yearly Total Debt VS Total AssetsISPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -10.04, we must say that ISPC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -10.04, ISPC is doing worse than 86.49% of the companies in the same industry.
There is no outstanding debt for ISPC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.04
ROIC/WACCN/A
WACC9.82%
ISPC Yearly LT Debt VS Equity VS FCFISPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ISPC has a Current Ratio of 0.74. This is a bad value and indicates that ISPC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.74, ISPC is doing worse than 81.08% of the companies in the same industry.
A Quick Ratio of 0.74 indicates that ISPC may have some problems paying its short term obligations.
ISPC has a worse Quick ratio (0.74) than 81.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
ISPC Yearly Current Assets VS Current LiabilitesISPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

ISPC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.26%, which is quite good.
ISPC shows a small growth in Revenue. In the last year, the Revenue has grown by 0.69%.
ISPC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.73% yearly.
EPS 1Y (TTM)17.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.35%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y6.67%
Revenue growth 5Y17.73%
Sales Q2Q%-4.24%

3.2 Future

ISPC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.24% yearly.
The Revenue is expected to grow by 9.14% on average over the next years. This is quite good.
EPS Next Y96.29%
EPS Next 2Y40.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.58%
Revenue Next 2Y9.14%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ISPC Yearly Revenue VS EstimatesISPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ISPC Yearly EPS VS EstimatesISPC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ISPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ISPC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ISPC Price Earnings VS Forward Price EarningsISPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPC Per share dataISPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

ISPC's earnings are expected to grow with 40.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ISPC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPECIMEN INC

NASDAQ:ISPC (1/17/2025, 8:08:49 PM)

After market: 2.4896 +0.12 (+5.05%)

2.37

-0.48 (-16.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners2.44%
Inst Owner Change0%
Ins Owners14.3%
Ins Owner Change0%
Market Cap2.28M
Analysts82.86
Price TargetN/A
Short Float %8.74%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-475.06%
Min EPS beat(2)-983.59%
Max EPS beat(2)33.47%
EPS beat(4)1
Avg EPS beat(4)-249.26%
Min EPS beat(4)-983.59%
Max EPS beat(4)33.47%
EPS beat(8)4
Avg EPS beat(8)-116.8%
EPS beat(12)5
Avg EPS beat(12)-70.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.04%
Min Revenue beat(2)-11.51%
Max Revenue beat(2)-2.56%
Revenue beat(4)0
Avg Revenue beat(4)-13.03%
Min Revenue beat(4)-21.06%
Max Revenue beat(4)-2.56%
Revenue beat(8)3
Avg Revenue beat(8)-7.45%
Revenue beat(12)4
Avg Revenue beat(12)-9.22%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-18.7
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-6.24
FCFYN/A
OCF(TTM)-4.53
OCFYN/A
SpS10.82
BVpS4.91
TBVpS-1.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -84.55%
ROE -202.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.97%
FCFM N/A
ROA(3y)-45.63%
ROA(5y)-64.82%
ROE(3y)-64.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.92%
GM growth 5Y2.16%
F-Score3
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.92%
Cap/Sales 15.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z -10.04
F-Score3
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)197.71%
Cap/Depr(5y)192.03%
Cap/Sales(3y)29.27%
Cap/Sales(5y)27.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.35%
EPS Next Y96.29%
EPS Next 2Y40.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y6.67%
Revenue growth 5Y17.73%
Sales Q2Q%-4.24%
Revenue Next Year6.58%
Revenue Next 2Y9.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.25%
OCF growth 3YN/A
OCF growth 5YN/A